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dvanced glycation end product
a  b  s  t  r  a  c  t
One of the  pathways  involved  in the  pathogenesis  of  diabetic  complications  is the  forma-
tion  of  excessive  levels  of advanced  glycation  end  (AGE)  products.  N-carboxymethyllysine
(CML)  is one  of the  best-characterized  AGEs.  Because  little  is  known  about  the  effects  of
AGEs on  pancreatic  beta  cells,  we  investigated  the  effect  of CML  on  human  pancreatic  cells
and  determined  the activity  and  gene  expression  of glutathione  system  components.  CML
at a concentration  of 0.5  mM  induced  cell  death  in  human  pancreatic  beta  cells,  which  was
accompanied  by  increased  intracellular  oxidative  stress.  No changes  in the  gene  expres-
sion of  the  receptor  for AGEs  (RAGE)  were  found,  although  an  increase  in the  level of  a
target  cytokine  of  RAGE  after  CML  exposure  was  observed.  Additionally  we found  that  CML
lowered the  levels  of GSH  and  affected  the  activity  and  expression  of other  componentsxidative stress of  the  glutathione  system.  These  changes  indicate  that the  cells  are  even  more  vulnerable
for  oxidative  stress  after  exposure  to CML.  Since  beta  cells  are low  in  antioxidant  enzymes
and  repair  for  oxidized  DNA, CML,  but most  likely  also  other  AGEs,  accelerates  beta  cell
dysfunction  and  increases  beta  cell  death  during  chronic  hyperglycemia.
© 2014  The  Authors.  Published  by  Elsevier  Ireland  Ltd. This  is  an  open  access  article  under
Y-NC-Nthe CC  B
. Introduction
Hyperglycemia, which occurs during type 2 diabetes, is
ssociated with oxidative stress [1]. Formation of advanced
lycation end products (AGEs) is one of the mechanisms
hat results in the increased formation of oxygen radicals.
GEs constitute a heterogeneous group of macromolecules
ormed by the non-enzymatic glycation of proteins, lipids
nd  nucleic acids. AGEs can be ingested with food and
re  also formed in small amounts endogenously in the
ody  as a consequence of normal metabolism [2]. During
∗ Corresponding  author at: Department of Toxicology, PO Box 616, 6200




214-7500/© 2014 The Authors. Published by Elsevier Ireland Ltd. Th
http://creativecommons.org/licenses/by-nc-nd/3.0/).D  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
prolonged hyperglycemia AGEs can contribute to diabetic
complications by the formation of crosslinks in the basal
membrane and accumulation of glycated proteins which
alters  cellular structure and protein functions. Further-
more, interaction with the receptor for AGE (RAGE) leads to
the  expression of pro-inﬂammatory genes like interleukin-
8  (IL-8) and monocyte chemoattractant protein-1 (MCP-1)
[3,4].  N-carboxymethyllysine (CML) is one of the best-
characterized AGEs. Elevated levels of serum CML  have
been  associated with arterial stiffness and pose a higher
risk  of cardiovascular and all-cause mortality [5–7].
Pancreatic beta cells appear to be particularly vulnera-
ble for oxidative stress. Expression and activity of the key
antioxidant enzymes superoxide dismutase (SOD), catalase
(CAT)  and glutathione peroxidase (GPx) is low in beta cells
compared to other cell types [8]. Moreover, beta cells were
found  incapable to adapt their antioxidant enzyme activity
is is an open access article under the CC BY-NC-ND license
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in response to oxidative stress [9]. In addition, it was  shown
that  pancreatic islets possess low repair machinery for oxi-
dized  DNA [10]. Although a lot of research has focused on
the  amount of antioxidant enzymes in pancreatic islets and
the  effect of overexpression of GPx, little is known about
the  levels and role of other components of the glutathione
system in the beta cell.
Glutathione, a tripeptide (-glutamylcysteinylglycine),
is the major free thiol in most living cells and it is involved
in  many biological processes. Within cells, GSH is found
in  both the reduced sulfhydryl form (GSH) and the glu-
tathione disulﬁde oxidized form (GSSG). Under normal
conditions, more than 90% of the glutathione pool is present
in  the reduced form. The balance between GSH and GSSG
is  tightly regulated in the cell, as a decrease in GSH can put
the  cell at risk for oxidative damage. An increased GSSG to
GSH  ratio is therefore often considered as an indicator of
oxidative  stress [11].
Glutathione  has a diversity of crucial physiological roles,
but  it principally serves as an endogenous antioxidant. It
functions  as a cofactor for GPx, the major defense mecha-
nism  against potential toxic hydrogen peroxide and other
peroxides [12]. During the detoxiﬁcation process of per-
oxides,  GSSG is formed. GSH is regenerated from GSSG by
the  NADPH-dependent enzyme glutathione reductase (GR)
[13].  Additionally, glutathione S-transferase (GST) uses
GSH  as a substrate to form conjugates with electrophiles,
resulting in more water soluble metabolites which are
more  readily excreted. Glutaredoxin (Grx) utilizes the
reducing power of glutathione to catalyze disulﬁde reduc-
tions  in the presence of NADPH and GR. Grx is involved in
regulation  of various cellular functions, including electron
transport and protein folding [14].
Because little is known about the effects of AGEs on
pancreatic beta cells, we investigated the effect of CML  on
pancreatic  cell viability and determined the activity and
expression of components belonging to the glutathione
system.
2. Materials and methods
2.1.  Chemicals
All  chemicals were purchased from Sigma–Aldrich
(Steinheim, Germany) unless stated otherwise. CML  was
obtained  from SyMO-Chem BV (Eindhoven, Netherlands).
Roswell Park Memorial Institute (RPMI) 1640 medium,
Hank’s Balanced Salt Solution (HBSS), trypsin-EDTA
(1x), non-heat inactivated fetal calf serum (FCS), and
l-glutamine were obtained from Gibco (Breda, The
Netherlands).
2.2.  Cell culture
The  human pancreatic beta cell line 1.1E7 [15] was
obtained from HPA Culture Collections. Cells were cultured
in  RPMI 1640 medium with 10% non-heat inactivated FCS
and  2 mM l-glutamine. Cells were maintained in T75 ﬂasks
at  37 ◦C in a 5% CO2 atmosphere. Reports 1 (2014) 973–980
2.3.  MTT assay
Cells  were seeded at a density of 5000 cells per well
in a 96-well plate and after overnight attaching, medium
was  removed and cells were washed with HBSS. CML  was
added  to the plate in different concentrations (0–1 mM).
Subsequently, cells were incubated for 24 h. After treat-
ment, supernatant was  removed and cells were washed
with PBS. Next, 100 l of MTT  solution (0.5 mg/ml  in cul-
ture  medium) was  added and cells were incubated for 1 h
at  37 ◦C. After incubation, the plate was  washed with PBS
and  the formazan crystals were dissolved in 200 l DMSO.
Cells  were incubated for 30 min  after which the absorbance
at  540 nm was  measured spectrophotometrically using a
microplate  reader. Relative viability is expressed as a per-
centage  relative to untreated cells.
2.4. Measurement of intracellular oxidative stress
The production of intracellular reactive oxygen species
was  measured using 2,7-dichloroﬂuorescein diacetate
(DCFH-DA) as described previously [16,17]. Cells were
seeded at a density of 5000 cells per well in a 96 well plate
and  after overnight attaching, medium was  removed and
cells  were washed with HBSS. Cells were then incubated
with 0.5 mM CML  in the presence of 10 M DCFH-DA. After
24  h, cells were washed with PBS to remove any DCFH-DA
that was  not taken up by the cells. Fluorescence (excitation
485 nm;  emission 535 nm)  was  measured with the use of a
microplate  reader.
2.5.  Gene expression analysis
RNA  was  isolated from Qiazol suspended cells according
to  the manufacturer’s protocol and quantiﬁed spectropho-
tometrically. Reverse transcription reaction was  performed
using  500 ng of RNA, which was  reverse-transcribed into
cDNA  using iScriptTM cDNA synthesis kit (Biorad, Veenen-
daal, The Netherlands). Next, real time PCR was  performed
with a BioRad MyiQ iCycler Single Color RT-PCR detec-
tion  system using SensimixTMPlus SYBR and Fluorescein
(Quantace-Bioline, Alphen a/d Rijn, The Netherlands), 5 l
diluted  (10×) cDNA, and 0.3 M primers in a total volume
of  25 l. PCR was  conducted as follows: denaturation at
95 ◦C for 10 min, followed by 40 cycles of 95 ◦C for 15 s
and  60 ◦C for 45 s. After PCR, a melt curve (60–95 ◦C) was
produced for product identiﬁcation and purity. -actin
was  included as internal control. Primer sequences are
shown  in Table 1. Data were analyzed using the MyIQ soft-
ware  system (BioRad) and were expressed as relative gene
expression (fold change) using the 2Ct method.
2.6.  Cytokine release
1.1E7  cells were incubated with 0.5 mM CML  for 24 h.
After  incubation, culture medium was collected. Cytokines
released in the supernatant of the cells were measured
using the Bio-plex pro assay according to manufac-
turer’s instructions. This assay uses antibodies coupled
to  magnetic beads which react with 50 l supernatant.
After a series of washes to remove unbound protein,
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Table 1
Sequences of the primers used in gene expression analysis.
Gene Forward (5′–3′) Reverse (5′–3′)
Beta-actin (-actin) CCTGGCACCCAGCACAAT GCCGATCCACACGGAGTACT
Receptor for AGE (RAGE) GGCCAGGGCTAGAGTTCC GCTGTCAGCATCAGCATCAT












































Glutathione S-transferase pi (GSTP1)
Glutaredoxin-2 
cytokine-speciﬁc biotinylated detection antibody was
dded  to the reaction. After 30 min  incubation and several
ashes, a streptavidin-phycoerythrin (streptavidin-PE)
eporter complex was added to bind biotinylated detec-
ion  antibodies. The plate was then read using the Luminex
ystem and data was analyzed using the Bio-Plex Manager
oftwareTM.
.7.  GSH/GSSG levels
1.1E7  cells were incubated with 0.5 mM CML  for 24 h.
fter  incubation, cells were washed with PBS, harvested
ith trypsin-EDTA and centrifuged (1000 × g, 5 min, 4 ◦C).
ext,  cells were washed with ice-cold PBS and centrifuged
gain. Cell pellets were then resuspended in ice-cold
xtraction buffer (0.1% Triton X-100 and 1.3% SSA in a 0.1 M
otassium  phosphate buffer with 5 mM EDTA, pH 7.5) and
onicated  in icy water for 10 min. The extracts were used
or  determination of intracellular GSH and GSSG content
sing an enzymatic recycle method described by Rahman
t  al. [18].
.8.  Glutathione reductase activity
1.1E7 cells were incubated with 0.5 mM CML  for 24 h.
fter  incubation, cells were washed with HBSS, harvested
ith trypsin-EDTA and centrifuged (1000 × g, 5 min, 4 ◦C).
ell  pellets were then resuspended in 145 mM sodium
hosphate buffer pH 7.4 containing 1 mM EDTA. Next, cells
ere  sonicated in icy water for 10 min  and centrifuged
15 min, 10,000 × g, 4 ◦C). Final reaction mixture (1 ml)
ontained 0.06 mM NADPH (in 1% Na2CO3) and 50 l sam-
le  in buffer. The reaction was started by the addition of
.225  mM GSSG (in 0.01 M NaOH). The consumption of
ADPH  was followed by the decrease in absorbance at
40  nm for 3 min  at 37 ◦C. Activity was corrected for protein
ontent of the samples and expressed in nmol/mg protein
er  minute.
.9. Glutathione transferase activity
1.1E7 cells were incubated with 0.5 mM CML  for 24 h.
fter  incubation, cells were washed with HBSS, harvested
ith trypsin-EDTA and centrifuged (1000 × g, 5 min, 4 ◦C).
ell  pellets were then resuspended in 100 mM potassium
hosphate buffer pH 6.5 containing 6.3 mM EDTA. Next,
ells  were sonicated in icy water for 10 min  and centrifuged
15 min, 10.000 × g, 4 ◦C). Final reaction mixture (1 ml)  con-
ained  1 mM  GSH and 50 l sample in buffer. The reaction
as started by the addition of 1 mM CDNB (in ethanol).
he production of GS-dinitrobenzene was followed by the
ncrease  in absorbance at 340 nm for 3 min  at 37 ◦C. WithCAAGCTGGGTGGCACTTG TTGGAAAGCCATAATCAGCA
GCTCTATGGGAAGGACCAG CTCAAAAGGCTTCAGTTGC
CCGTCGCTAAATTCTCCAAA TGGCACTCGCTGGAATC
each  run a spontaneous reaction was  included that con-
tained  buffer instead of a sample. Activity was corrected
for spontaneous reaction and for protein content of the
samples and expressed in mol/mg protein per minute.
2.10. Glutaredoxin activity
1.1E7  cells were incubated with 0.5 mM CML  for 24 h.
After  incubation, cells were washed with HBSS, harvested
with trypsin-EDTA and centrifuged (1000 × g, 5 min, 4 ◦C).
Cell  pellets were then resuspended in 100 mM potassium
phosphate buffer pH 7.0 containing 1 mM EDTA. Next, cells
were  sonicated in icy water for 10 min  and centrifuged
(15 min, 10,000 × g, 4 ◦C). Final reaction mixture (1 ml)
contained 0.5 mM GSH, 0.2 mM  NADPH, 1 U glutathione
reductase and 50 l sample in buffer. The reaction was
started by the addition of 0.35 mM 2-hydroxyethyl disul-
ﬁde  (HED). The decrease in absorbance at 340 nm,  which
accompanies the oxidation of NADPH, was monitored for
3  min  at 37 ◦C. Activity was  corrected for protein content of
the  samples and expressed in mol/mg protein per minute.
2.11.  Protein determination
Protein  concentrations were determined spectropho-
tometrically using the DC protein assay kit (Biorad,
Veenendaal, The Netherlands) according to manufacturer’s
protocol.
2.12. Statistical analysis
The  effect of CML  incubation was  tested using Student’s
t-test for independent samples or the Mann–Whitney U
test  when not normally distributed. P-Values <0.05 were
considered statistically signiﬁcant and P-values <0.1 were
considered statistical trends. We  also include statistical
trends because for bioactive molecules like GSH, even a
small  percentage change in the amount can be of biological
relevance. Statistical analyses were analyzed with SPSS for
Windows  (version 20.0; SPSS Inc., Chicago, IL, USA).
3.  Results
3.1. CML exposure causes a decrease in viability in beta
cells
The  effect of CML  exposure on 1.1E7 cell viability was
determined by MTT  assay (Fig. 1A). At concentrations up
to  0.125 mM a dose-dependent decrease in viability of
100–87%  was observed, albeit with a high degree of varia-
tion  between the different experiments. Above 0.125 mM
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ethyllysine (CML) (0–1 mM)  for 24 h on cell viability of human beta cells (A).
ess (B). Data are expressed as mean ± standard error of the mean (SEM) of three
n-exposed cells.Fig. 1. The effect of exposure to different concentrations Nε-carboxym
Incubation  with 0.5 mM CML  for 24 h increases intracellular oxidative str
(MTT)  or four (DCFH) independent experiments. *p < 0.05 compared to no
the additional decrease in viability was only 4%. CML  con-
centrations higher than 0.25 mM show a lower degree
of  variation between the experiments and concentrations
higher than 0.5 mM did not show an additional decrease
in  viability, therefore a CML  concentration of 0.5 mM was
chosen  as the exposure condition.
3.2. CML  exposure causes an increase in intracellular
oxidative stress
To  determine intracellular levels of reactive oxygen
species we used the ﬂuorogenic dye DCFH-DA. After diffu-
sion  into the cell, DCFH-DA is enzymatically hydrolyzed by
esterases  to the non-ﬂuorescent compound DCFH. When
ROS  are present, DCFH can be oxidized to the highly ﬂu-
orescent compound DCF. After 24 h exposure to CML  we
found  a 23% increase in DCF ﬂuorescence (Fig. 1B). This indi-
cates  that CML  causes a signiﬁcant increase in intracellular
oxidative stress in the beta cell.
3.3. CML  exposure increases the levels of MCP-1 in the
culture medium
Because AGEs bind to RAGE, we measured the gene
expression of this receptor in the beta cells. We  did not
observe an effect on gene expression after exposure to
CML  (Fig. 2A). Since RAGE activation is associated with
an  increase in pro-inﬂammatory genes, the levels of IL-8
and  MCP-1, cytokines which are known to be upregu-
lated by RAGE were investigated in the supernatant of cells
exposed  to CML  [19–21]. No effects on the levels of IL-8
were  observed (Fig. 2B). MCP-1 levels were increased by
almost  40% (Fig. 2C). Other RAGE associated cytokines were
also  measured with the Luminex system, but these data
are  not included because the concentrations were below
detection limit.
3.4.  Effect on components of the glutathione system
We  determined the activity and gene expression of sev-
eral  components of the glutathione system. We  observed
a  trend to a lower GSH concentration of the cells after
CML  exposure (Fig. 3A). The GSSG concentration did not
change,  but was very low and below the detection limit
in  some samples (Fig. 3B). The expression of the enzyme
gamma-glutamylcystein synthetase (-GCS), involved in
Fig. 2. The effect of exposure to 0.5 mM CML  for 24 h on gene expression
of RAGE (A) and the levels of two  cytokines which are elevated by RAGE
signaling, IL-8 (B) and MCP-1 (C). Data are expressed as mean ± standard
error of the mean (SEM) of three (RAGE expression) or four (IL-8 and MCP-
1)  independent experiments. #p < 0.1 compared to non-exposed cells.
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big. 3. The effect of exposure to 0.5 mM CML  for 24 h on GSH content (A
-GCS)  (C). Data are expressed as mean ± standard error of the mean (SE
he biosynthesis of GSH, was not affected by exposure to
ML  (Fig. 3C).
A  trend toward decreased activity of GR after CML  expo-
ure  was detected, which was not accompanied by a change
n  gene expression of this enzyme (Fig. 4A and B). We  also
easured GST activity, which did not show any change
fter CML  exposure (Fig. 4C). Because GST is a large family
f  genes, the expression of one speciﬁc class was  deter-
ined. Glutathione S-transferase pi (GSTP1) was chosen
ecause its overexpression has been linked to the preven-
ion  of oxidative stress [22,23]. We  found an upregulation
n the expression of GSTP1 when cells were exposed to
ML  for 24 h (Fig. 4D). We  did not ﬁnd any signiﬁcant
hanges in glutaredoxin activity or gene expression (Fig. 4E
nd  F).
.  Discussion
AGE formation is one of the major pathways by which
yperglycemia can cause diabetic complications, therefore
GEs  contribute to the pathogenesis of diabetes [24]. Beta
ell  dysfunction and death is involved in the progression
f diabetes [25]. In this study we investigated the effect of
xposure  with the AGE CML  on a human pancreatic beta
ell  line.
In  this study we used a concentration of 0.5 mM CML
o  induce changes in glutathione components. This con-
entration is higher than usually found in the plasma of
iabetic  patients, typically reported in the nanomolar or
ow  micromolar range [26–28]. This high concentration
as chosen to determine the effects of CML  in a relatively
hort incubation time of 24 h. Since we also use FCS in this
odel,  it is possible that CML  binds to FCS and that the
ctual amount of free CML  reacting with the cells is much
ower  than 0.5 mM and might even be in the in vivo range.
Only  a limited number of studies about the effect of AGE
n  beta cell viability and function have been published.
 study in a mouse beta cell line found that exposure to
GEs  increased superoxide production in the mitochon-
ria, which led to an impairment of insulin secretion [29].
ncreased oxidative stress via the mitochondria due to
xposure to AGEs was also found in rat beta cells [30].
xposure of different rodent beta cell lines to AGEs induced
oth  proliferation and apoptosis in these cells [31]. In line
ith  these studies, we also observed a decrease in beta cell
iability  after exposure to the AGE CML. This decreased via-
ility  was accompanied by an increase in oxidative stress content (B) and gene expression of gamma-glutamylcystein synthetase
ree independent experiments. #p < 0.1 compared to non-exposed cells.
which  probably results from the interaction of CML  with
RAGE.
RAGE  is a multiligand transmembrane receptor which
belongs to the immunoglobulin gene superfamily [32].
Activation of RAGE by AGEs transduces multiple signals
resulting in activation and translocation of nuclear tran-
scription factors like NF-B [4]. This leads to the expression
of proinﬂammatory cytokines, including IL-8 and MCP-1
[19–21]. It has been shown that CML  adducts are signal-
transducing ligands for RAGE, both in vitro and in vivo [33].
However, another study found that CML-modiﬁed proteins
were  unable to bind to RAGE and activate proinﬂammatory
signaling [34]. No changes in the gene expression of RAGE
after  exposure to CML  were found, but this may  be due
to  the relatively short incubation time of 24 h. However,
increased concentrations of the proinﬂammatory cytokine
MCP-1 were detected, which could be caused by RAGE
signaling, as MCP-1 is known to be regulated by RAGE. MCP-
1  is involved in the pathogenesis of diabetic nephropathy
[35] and is also implicated in the destruction of beta
cells in type 1 diabetes [36]. The rise in MCP-1 levels
could explain the observed increase in intracellular oxida-
tive  stress in these cells since MCP-1 has been associated
with the induction of oxidative stress in previous studies.
MCP-1 enhanced ROS generation in monocytes from unsta-
ble  angina patients [37]. Additionally, MCP-1-deﬁciency
impaired ROS generation and attenuated oxidative stress in
an  ovariectomy rodent model (as a model for menopause)
[38].
Previous research has shown that AGEs can increase
GSSG levels in human neuroblastoma cells [39]. Also in vivo
an  association between AGEs and a decreased glutathione
redox ratio in patients undergoing continuous ambula-
tory peritoneal dialysis was  found [40]. We  found a trend
toward a decrease in GSH content in beta cells exposed to
CML.  The amount of GSSG was  already very low and no
further  change could be detected after CML  exposure. A
decrease  in GSH content has been associated with diabetes
in  previous studies, e.g. levels of GSH were lower in eryth-
rocytes of type 2 diabetes patients [41]. This decrease was
associated with a lower activity of the enzyme -GCS which
is  involved in the biosynthesis of GSH [41]. We  did not ﬁnd
a  change in gene expression of -GCS after exposing the
cells  to CML.Replenishment of the GSH pool by GR is dependent on
the  GSSG pool and the availability of NADPH. Since we do
not  see changes in the GSSG concentration, the amount of
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Fig. 4. The effect of exposure to 0.5 mM CML  for 24 h on activity (A) and gene expression (B) of glutathione reductase; activity of glutathione transferase
of gluta
ty) inde(C)  expression of GSTP1 (D); activity of glutaredoxin (E) and expression 
(SEM)  of three (gene expression, GR activity) or four (GST and Grx activi
compared  to non-exposed cells.
available NADPH limits the glutathione reductase activity
after  CML  exposure.
CML  increased the expression of GST in both cell cul-
ture  and animal models [42]. However, they also found
increased GSH concentrations with a higher expression of
GST.  This seemed to be associated with activation of the
transcription factor AP-1 by RAGE, which in turn might be
involved  in the induction of GST and -GCS [42]. We  did
ﬁnd  an increase in GSTP1 expression, however we did not
ﬁnd  an increase in expression of RAGE and -GCS, which
could explain why we did not ﬁnd an increase in GSH.It  is known that expression of Grx is high in beta cells
and that Grx might play a regulatory role in insulin exo-
cytosis [43]. Glutaredoxin-1 expression has been linked to
diabetic  retinopathy, by inducing NF-B translocation andredoxin-2 (F). Data are expressed as mean ± standard error of the mean
pendent experiments. *p < 0.05 compared to non-exposed cells; #p < 0.1
expression  of intercellular adhesion molecule-1 (ICAM-1)
in  rat retinal Müller cells [44]. A recent study in patients
with abnormal glucose levels found a higher Grx activity in
plasma  and serum of these patients compared to healthy
subjects [45]. We  did not ﬁnd any signiﬁcant changes after
24  h exposure to CML  in activity levels of Grx or expression
of  glutaredoxin-2.
In conclusion, we found that CML  was able to induce cell
death  in human pancreatic beta cells, which was  accom-
panied by an increase in intracellular oxidative stress. We
did  not ﬁnd changes in the expression of RAGE, but we
found  an increase in the level of a target cytokine of RAGE
after  CML  exposure. Additionally we found that CML  expo-
sure  lowered the levels of GSH. Also other components of
the  glutathione system were affected, we found a decrease
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Fig. 5. Overview of the glutathione system and the effects of 24 h incubation with 0.5 mM Nε-carboxymethyllysine (CML) on this system in pancreatic beta
c ); GR, g
t d form)
















[ells.  GSH, glutathione (reduced form); GSSG, glutathione (oxidized form
ransferase; NADP, nicotinamide adenine dinucleotide phosphate (oxidize
2O2, hydrogen peroxide; H2O, water; SSG, glutathione adduct to protein
n glutathione reductase activity and an increase in the
xpression of GSTP1 (Fig. 5). These changes in GSH lev-
ls  and activities of components of the glutathione system
ndicate that the cells are even more vulnerable for oxida-
ive  stress after exposure to CML. Since beta cells are low in
ntioxidant enzymes and repair for oxidized DNA, it might
e  that AGEs like CML  can accelerate beta cell dysfunction
nd beta cell death during hyperglycemia.
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